The rationale for antidepressants in the treatment of schizophrenia: A modern view on the problem in the context of evidence-based medicine

The rationale for antidepressants in the treatment of schizophrenia: A modern view on the problem in the context of evidence-based medicine

The paper discusses whether antidepressant treatment is rational in schizophrenics. It analyzes the results from trials evaluating the efficiency of the therapy in patients with depressive, negative, or obsessive-phobic symptoms. The validity of results of these trials is assessed. The results of de...

Full description

Bibliographic Details
Main Authors:	D. S. Danilov, D. O. Magomedova, M. E. Matsneva
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2016-03-01
Series:	Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:	antidepressants selective serotonin reuptake inhibitors schizophrenia depression negative symptoms obsessive-phobic (obsessivecompulsive) symptoms evidence-based medicine observational studies
Online Access:	https://nnp.ima-press.net/nnp/article/view/586

Similar Items

Chirality of Modern Antidepressants: An Overview
by: Monica Budău, et al.
Published: (2017-12-01)

Antidepressants and cardiovascular adverse events: A narrative review
by: Mohammad Hassan Nezafati, et al.
Published: (2015-09-01)

Prevalence of obsessive compulsive symptoms among patients with schizophrenia
by: Smita Hemrom, et al.
Published: (2009-01-01)

PSYCHOPHARMOCOTHERAPY FOR PHOBIC AND OBSESSIVE-COMPULSIVE DISORDERS IN SCHIZOPHRENIA SPECTRUM STATES
by: A. V. Pavlichenko, et al.
Published: (2009-12-01)

Antidepressant Drugs Effects on Blood Pressure
by: Anna Calvi, et al.
Published: (2021-08-01)

Exploratory Study of Obsessive Compulsive Symptoms in Schizophrenia
by: E Sivabalan, et al.
Published: (2017-01-01)

Experimental Serotonergic Agents for the Treatment of Schizophrenia
by: Capuzzi E, et al.
Published: (2021-02-01)

Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice
by: Pranav Sikka, et al.
Published: (2011-01-01)

Commentary: Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.
by: Eiko I Fried, et al.
Published: (2015-08-01)

Neuroanatomical, neurochemical, and neurodevelopmental basis of obsessive-Compulsive symptoms in schizophrenia
by: Venkatasubramanian Ganesan, et al.
Published: (2009-01-01)

Pervalence of Negative Symptoms in Schizophrenia
by: Saeed Shoja-Shefti, et al.
Published: (2002-10-01)

Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function.
by: Nathan C Mitchell, et al.
Published: (2013-10-01)

Obsessive-Compulsive Symptoms Associated with Clozapine and Risperidone Treatment: Three Case Reports and Review of the Literature
by: Chiao-Li Ke, et al.
Published: (2004-06-01)

Chronic antidepressant treatment accelerates kindling epileptogenesis in rats
by: Lisa Cardamone, et al.
Published: (2014-03-01)

Negative symptoms in schizophrenia
by: Sayantanava Mitra, et al.
Published: (2016-01-01)

Analytical methods for determination of selective serotonin reuptake inhibitor antidepressants
by: Şentürk Zühre, et al.
Published: (2011-06-01)

Determine the Effect of a Mindfulness Training on Marital Satisfaction and Obsessive - Compulsive Womenin Yazd
by: S Ashiri, et al.
Published: (2016-03-01)

The Effectiveness of Humor Skills Training on Positive and Negative Symptoms of Chronic Schizophrenia Spectrum
by: Akbar Atadokht, et al.
Published: (2019-01-01)

Obsessive-Compulsive Disorder in Hospitalized Patients with Schizophrenia
by: Mercedeh Samiei, et al.
Published: (2016-10-01)

Refining the clinical features of serotonin syndrome: A prospective observational study of 45 patients
by: Sanjay Prakash, et al.
Published: (2019-01-01)

The effect of obsessive compulsive symptoms on psychopathology in patients with schizophrenia
by: Ng Boon Seng, et al.

Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
by: Hui Wen, et al.
Published: (2019-01-01)

Possible sertraline-induced extrapyramidal adverse effects in an adolescent
by: Wang LF, et al.
Published: (2016-05-01)

Sertraline induced acute mandibular dystonia
by: Dhanya Raveendranathan, et al.
Published: (2015-10-01)

Symptom Cluster-Matching Antidepressant Treatment: A Case Series Pilot Study
by: Sławomir Murawiec, et al.
Published: (2021-05-01)

The Relationship between Obsessions and Compulsions and Negative and Positive Symptoms in Schizophrenia.
by: Neda Nasrollahi, et al.
Published: (2012-09-01)

The Relationship between Obsessions and Compulsions and Negative and Positive Symptoms in Schizophrenia
by: Neda Nasrollahi, et al.
Published: (2012-09-01)

Autism Spectrum Disorder and Schizophrenia Are Better Differentiated by Positive Symptoms Than Negative Symptoms
by: Dominic A. Trevisan, et al.
Published: (2020-06-01)

Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history
by: D. S. Danilov
Published: (2018-12-01)

Insight in schizophrenia: Relationship to positive, negative and neurocognitive dimensions
by: Boban Joseph, et al.
Published: (2015-01-01)

Perception of burden by caregivers of patients with schizophrenia in relation to symptom profile
by: Bharathi Gunjahalli, et al.
Published: (2019-01-01)

Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
by: Bahrick, A., et al.
Published: (2022)

Schizophrenia: human and animal studies
by: Ahmed A. Moustafa, et al.
Published: (2016-04-01)

Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
by: P N Suresh Kumar, et al.
Published: (2016-01-01)

Trends in Antidepressant Use and Expenditure in Six Major Cities in China From 2013 to 2018
by: Zhenwei Yu, et al.
Published: (2020-07-01)

Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants’ Efficacy and Harm
by: Michael P. Hengartner
Published: (2017-12-01)

Obesogenic Behavior and Binge Eating Disorder in an Elderly Female with Schizophrenia
by: Vishnupriya Veeraraghavan
Published: (2021-06-01)

Working memory and Parkinsonism due to antipsychotic medications in Schizophrenia
by: Amir eSalem, et al.
Published: (2015-05-01)

Main methods of psychotherapy for negative schizophrenia symptoms
by: A. O Munin, et al.
Published: (2020-12-01)

Intense suicidal thoughts and self-harm following escitalopram treatment
by: Farooq Khan, et al.
Published: (2011-01-01)